Blue Edge Capital’s Pfizer PFE Stock Holding History

Blue Edge Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$259K	Buy	9,225 +711	+8%	+$18.9K	0.03%	125
2025 Q4	$212K	Buy	+8,514	New	+$215K	0.03%	125

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Blue Edge Capital's PFE Position: Q1 2026 in Review

Blue Edge Capital increased its Pfizer (PFE) stake by 8.4% in Q1 2026, buying an estimated $18.9K and bringing the position to 9,225 shares worth $259K. The position accounts for 0.03% of the portfolio, ranked #125.

Blue Edge Capital first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Blue Edge Capital held 9,225 shares of Pfizer worth $259K as of Q1 2026.
Blue Edge Capital bought 711 Pfizer shares in Q1 2026, an estimated $18.9K.
Pfizer made up 0.03% of Blue Edge Capital's portfolio in Q1 2026, its #125 holding.
Blue Edge Capital first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Blue Edge Capital's 13F filing for Q1 2026, filed 2 Jun 2026.